Syndopa 275 should be administered with caution in severe cardiovascular or pulmonary disease, bronchial asthma, renal, hepatic or endocrine disease and in presence of peptic ulcer or chronic wide-angle glaucoma.
If general anaesthesia is required, therapy with Syndopa 275 may be continued as long as the patient is permitted to take fluids and medications by mouth. If therapy is interrupted temporarily, the usual daily dosage may be administered as soon as the patient is able to take oral medication.
Use in Pregnancy: Use of Syndopa 275 in women of childbearing potential requires that the anticipated benefits of the drug be weighed against possible hazards to the mother and child.
Use in Children: Safety of the formulation has not been established in patients under 18 years of age.
Other Services
Country
Account